Pricing Log in Create free account

CervoMed Inc. (CRVO) vs IGC Pharma, Inc. (IGC)

CervoMed Inc. and IGC Pharma, Inc. are both Biotechnology companies. CervoMed Inc. and IGC Pharma, Inc. are of similar size ($22.0M and $21.9M). IGC Pharma, Inc. grew revenue faster over the last twelve months: −17.0% against −58.9%. CervoMed Inc. has the higher net margin (0.00% vs −836.1%) and the higher return on invested capital (0.00% vs −90.5%). Across the 17 metrics below, CervoMed Inc. leads on 11 and IGC Pharma, Inc. on 6.

Valuation

Metric CRVO IGC Biotechnology median
P/E n/m n/m 10.60
P/S 3.61 18.89 9.40
P/B 0.63 3.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.62 19.31 9.02
Earnings yield (228.37%) (47.37%) (32.88%)
Free cash flow yield (196.71%) (27.39%) (23.13%)

Profitability

Metric CRVO IGC Biotechnology median
Gross margin 100.00% 23.89% 68.51%
Operating margin 0.00% (914.80%) 0.00%
Net margin 0.00% (836.06%) 0.00%
Free cash flow margin 0.00% (485.92%) 0.00%
Return on equity (107.62%) (126.16%) (51.96%)
Return on assets (94.73%) (94.55%) (46.06%)
Return on invested capital 0.00% (90.48%) 0.00%

Growth

Metric CRVO IGC Biotechnology median
Revenue growth (TTM) (58.86%) (17.03%) 6.76%
EPS growth (last fiscal year) (47.52%) 57.85% 29.88%
Revenue growth, 5-year CAGR — (20.77%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO IGC Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 8.57 0.42 4.97
Net debt to EBITDA 0.74 0.04 1.01

Dividend

Metric CRVO IGC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVO IGC Biotechnology median
Market cap 21.93m 21.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack